By National Institutes of Health | July 17, 2018
Dasatinib, one of the two drugs in the senolytic cocktail used in the study, is an anti-cancer drug. The other drug in the cocktail, quercetin, is an antioxidant found in some foods.
Follow this link for the full story:
Last Reviewed: